These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23627246)

  • 21. Legislative/regulatory update from the International Academy of Compounding Pharmacists.
    Miller DG
    Int J Pharm Compd; 2012; 16(6):476-8. PubMed ID: 23259363
    [No Abstract]   [Full Text] [Related]  

  • 22. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing.
    Blankenship C
    Int J Pharm Compd; 2018; 22(2):125-126. PubMed ID: 29877859
    [No Abstract]   [Full Text] [Related]  

  • 24. Legislative/regulatory update from the International Academy of Compounding Pharmacists.
    Miller DG
    Int J Pharm Compd; 2012; 16(1):50-2. PubMed ID: 23050311
    [No Abstract]   [Full Text] [Related]  

  • 25. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
    Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A growing codependency: compounding pharmacy and safety.
    Prince B; Lundevall J
    Int J Pharm Compd; 2013; 17(6):485-9. PubMed ID: 24579299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 29. Compounding in Ukraine.
    Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
    Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Double, double, toil and trouble': for modern practitioners of compounding, standards and training are critical [interview by Lisa Santandrea].
    Allen LV
    Am J Nurs; 2003 May; 103(5):83. PubMed ID: 12762333
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Update on the Mali Pharmacy Code: legislative section].
    Maiga S; Haidara B; Thioune O; N'diaye B; Boye CS; Lo I
    Mali Med; 2010; 25(1):47-56. PubMed ID: 21435992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Under scrutiny. More control of compounding pharmacies sought.
    Lee J
    Mod Healthc; 2012 Oct; 42(43):12-3. PubMed ID: 23163094
    [No Abstract]   [Full Text] [Related]  

  • 35. Legislative/Regulatory Update FROM THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS: APPROPRIATIONS.
    McCrory G
    Int J Pharm Compd; 2016; 20(2):95-6. PubMed ID: 27323420
    [No Abstract]   [Full Text] [Related]  

  • 36. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacists' rights at front of new debate; because of beliefs, some refuse to fill birth control prescriptions.
    Stein R
    Washington Post; 2005 Mar; ():A1, A10. PubMed ID: 15838957
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
    de Souza HG; Favaro A; Andrade AL; Gomes LY; Garcez Mdo C
    Int J Pharm Compd; 2012; 16(2):98-102. PubMed ID: 23050320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why You Should Become an International Academy of Compounding Pharmacists Member.
    Gates EP
    Int J Pharm Compd; 2017; 21(1):28. PubMed ID: 28346195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.